KROS vs NVDA · rev $32.0K vs P/E 58, rev $96.22B
Keros Therapeutics Inc (KROS) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
KROS currently screens at market cap $208.8M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the KROS and NVDA stock pages for the full models.
Not investment advice.